Elixinol Wellness Statistics

Total Valuation

ASX:EXL has a market cap or net worth of AUD 4.86 million. The enterprise value is 5.72 million.

Market Cap	4.86M
Enterprise Value	5.72M

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:EXL has 220.82 million shares outstanding. The number of shares has increased by 160.95% in one year.

Current Share Class	n/a
Shares Outstanding	220.82M
Shares Change (YoY)	+160.95%
Shares Change (QoQ)	+47.80%
Owned by Insiders (%)	20.19%
Owned by Institutions (%)	2.72%
Float	165.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.32
PB Ratio	0.48
P/TBV Ratio	1.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.32
EV / Sales	0.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.62

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.19.

Current Ratio	1.44
Quick Ratio	0.54
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	-0.55
Interest Coverage	-23.83

Financial Efficiency

Return on equity (ROE) is -20.89% and return on invested capital (ROIC) is -32.07%.

Return on Equity (ROE)	-20.89%
Return on Assets (ROA)	-20.94%
Return on Invested Capital (ROIC)	-32.07%
Return on Capital Employed (ROCE)	-37.53%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.99
Inventory Turnover	2.54

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -84.70% in the last 52 weeks. The beta is 2.41, so ASX:EXL's price volatility has been higher than the market average.

Beta (5Y)	2.41
52-Week Price Change	-84.70%
50-Day Moving Average	0.03
200-Day Moving Average	n/a
Relative Strength Index (RSI)	21.39
Average Volume (20 Days)	172,777

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:EXL had revenue of AUD 14.96 million and -1.72 million in losses. Loss per share was -0.01.

Revenue	14.96M
Gross Profit	5.36M
Operating Income	-5.05M
Pretax Income	-5.31M
Net Income	-1.72M
EBITDA	-4.51M
EBIT	-5.05M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 1.08 million in cash and 1.94 million in debt, giving a net cash position of -862,000 or -0.00 per share.

Cash & Cash Equivalents	1.08M
Total Debt	1.94M
Net Cash	-862,000
Net Cash Per Share	-0.00
Equity (Book Value)	10.03M
Book Value Per Share	0.05
Working Capital	2.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.47 million and capital expenditures -60,000, giving a free cash flow of -3.53 million.

Operating Cash Flow	-3.47M
Capital Expenditures	-60,000
Free Cash Flow	-3.53M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 35.82%, with operating and profit margins of -33.78% and -11.51%.

Gross Margin	35.82%
Operating Margin	-33.78%
Pretax Margin	-35.51%
Profit Margin	-11.51%
EBITDA Margin	-30.17%
EBIT Margin	-33.78%
FCF Margin	n/a

Dividends & Yields

ASX:EXL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-160.95%
Shareholder Yield	-160.95%
Earnings Yield	-35.45%
FCF Yield	-72.64%

Stock Splits

The last stock split was on December 2, 2024. It was a reverse split with a ratio of 0.125.

Last Split Date	Dec 2, 2024
Split Type	Reverse
Split Ratio	0.125

Scores

ASX:EXL has an Altman Z-Score of -16.8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-16.8
Piotroski F-Score	n/a